Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La Rosa L, De Micheli V, Testa S, Frontoni R, Prisco D, Nante G, Iliceto S; Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic Therapies (FCSA). Pengo V, et al. Among authors: guazzaloca g. Circulation. 2009 Jun 9;119(22):2920-7. doi: 10.1161/CIRCULATIONAHA.108.823211. Epub 2009 May 26. Circulation. 2009. PMID: 19470892 Clinical Trial.
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register.
Palareti G, Antonucci E, Legnani C, Mastroiacovo D, Poli D, Prandoni P, Tosetto A, Pengo V, Testa S, Ageno W; START2 Register Investigators. Palareti G, et al. BMJ Open. 2020 Nov 27;10(11):e040449. doi: 10.1136/bmjopen-2020-040449. BMJ Open. 2020. PMID: 33247017 Free PMC article.
Risks factors for highly unstable response to oral anticoagulation: a case-control study.
Palareti G, Legnani C, Guazzaloca G, Lelia V, Cosmi B, Lunghi B, Marchetti G, Poli D, Pengo V; ad hoc Study Group of the Italian Federation of Anticoagulation Clinics*. Palareti G, et al. Among authors: guazzaloca g. Br J Haematol. 2005 Apr;129(1):72-8. doi: 10.1111/j.1365-2141.2005.05417.x. Br J Haematol. 2005. PMID: 15801958 Free article.
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation.
Taliani MR, Agnelli G, Prandoni P, Becattini C, Moia M, Bazzan M, Ageno W, Tomasi C, Guazzaloca G, Ambrosio GB, Bertoldi A, Salvi R, Poggio R, Silingardi M; Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Taliani MR, et al. Among authors: guazzaloca g. J Thromb Haemost. 2003 Aug;1(8):1730-3. doi: 10.1046/j.1538-7836.2003.00293.x. J Thromb Haemost. 2003. PMID: 12911585 Free article.
47 results